基质金属蛋白酶
胰腺癌
胰腺
癌症研究
癌症
生物
肿瘤进展
病理
胰腺炎
胰腺疾病
癌细胞
医学
内科学
内分泌学
作者
Volker Ellenrieder,Burkhard Alber,Ulrike Lacher,Sandra F. Hendler,André Menke,Wolfgang Boeck,Martin Wagner,Monika Wilda,Helmut Frieß,Markus W. Büchler,Guido Adler,Thomas M. Gress
标识
DOI:10.1002/(sici)1097-0215(20000101)85:1<14::aid-ijc3>3.0.co;2-o
摘要
Activation of matrix metalloproteinase-2 (MMP-2) by the membrane-type matrix metalloproteinases (MT-MMPs) has been associated with tumor progression. In the present study, we examined the role of MMP-2 and its activators MT1-MMP, MT2-MMP and MT3-MMP in pancreatic tumor cell invasion and the development of the desmoplastic reaction characteristic of pancreatic cancer tissues. Northern blot analyses revealed that transcript levels of MT1-MMP and MT2-MMP, but not MT3-MMP, were enhanced in pancreatic cancer tissues (n = 18) compared with both chronic pancreatitis (n = 9) and healthy pancreas (n = 9). A good correlation was found between MT1-MMP and both MMP-2 expression (p < 0.01) and activity in pancreatic cancer tissues. In addition, expression and activation of MMP-2 were strongly associated with the extent of the desmoplastic reaction in pancreatic cancer tissues. Invasion assays showed a good correlation between MMP-2 expression and activity and the invasive potential of pancreatic cancer cell lines. In cell lines with high levels of MMP-2 expression and activity, the MMP inhibitor Batimastat led to significant reduction of the number of invading cells. Our results suggest that MT1-MMP is involved in the progression of pancreatic cancer via activation of MMP-2. MMP-2 itself plays an important role in tumor cell invasion and appears to be associated with the development of the characteristic desmoplastic reaction in pancreatic cancer. Int. J. Cancer 85:14–20, 2000. © 2000 Wiley-Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI